AEGON ASSET MANAGEMENT UK Plc trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.4% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 54,413 shares of the healthcare conglomerate's stock after selling 760 shares during the period. AEGON ASSET MANAGEMENT UK Plc's holdings in UnitedHealth Group were worth $16,967,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in the business. Bayforest Capital Ltd lifted its position in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its position in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares in the last quarter. Kentucky Trust Co lifted its position in UnitedHealth Group by 53.8% in the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate's stock worth $45,000 after buying an additional 50 shares in the last quarter. O Brien Wealth Partners LLC lifted its position in UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after buying an additional 37 shares in the last quarter. Finally, Cloud Capital Management LLC purchased a new stake in UnitedHealth Group in the 1st quarter worth approximately $53,000. 87.86% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of research firms have recently weighed in on UNH. Baird R W downgraded shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Bank of America raised their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a "neutral" rating in a report on Wednesday, October 8th. Piper Sandler cut their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Barclays upped their target price on UnitedHealth Group from $352.00 to $386.00 and gave the stock an "overweight" rating in a research report on Thursday, October 9th. Finally, Robert W. Baird reiterated an "underperform" rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Seventeen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Hold" and a consensus target price of $384.09.
Read Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Stock Performance
NYSE UNH opened at $359.70 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market capitalization of $325.77 billion, a price-to-earnings ratio of 15.58, a P/E/G ratio of 2.32 and a beta of 0.47. The company's fifty day moving average is $322.74 and its two-hundred day moving average is $347.08. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the firm posted $6.80 earnings per share. UnitedHealth Group's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's payout ratio is 38.30%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.